Skip to content

To See and compare efficacy of JatyadiGhrita and Kampillakadi Taila Suppositories (Varti) for Acute Fissure-in-Ano

A Randomized Comparative Clinical Study to Evaluate the Efficacy of JatyadiGhrita and Kampillakadi Taila Suppositories in the Management of Acute Fissure-in-Ano. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093806
Enrollment
60
Registered
2025-08-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K600- Acute anal fissure

Interventions

None listed

Sponsors

Institute for Ayurved Studies & Research Shri Krishna AYUSH University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Symptoms of pain during defecation, bleeding per rectum, and visible linear ulcer, between Age group of 20-40 years, of either gender. Patients willing to undergo trial.

Exclusion criteria

Exclusion criteria: Age: below 20 years or above 40 years | Sex: both male and female] Patients who are diagnosed with conditions such as anal fistula, anorectal abscess, or Grade III?IV haemorrhoids will be excluded from the study. Individuals with immunosuppressive or systemic disorders, including Type 2 Diabetes Mellitus, HIV infection, Syphilis, Hepatitis B, Hepatitis C, Tuberculosis, or Crohn?s disease, will not be considered eligible. Patients with a history of anorectal or other malignancies, as well as pregnant or lactating women, will also be excluded. Furthermore, any patient deemed unsuitable for the investigational drug or with a known hypersensitivity or adverse reaction to the drug will not be included in the trial.

Design outcomes

Primary

MeasureTime frame
Reduction in pain during defecation (Visual Analogue Scale score)Timepoint: 1st- 0 Day 2nd- After completion of Trial 3rd- 1 Month after completion of follow?up?after?trial

Secondary

MeasureTime frame
1, Reduction in bleeding per rectum. 2, Improvement in local inflammation signs (Tenderness). 3, Patient compliance and recurrence rate during follow-up.Timepoint: 1st- 0 Day 2nd- After completion of Trial 3rd- 1 Month after completion of follow?up?after?trial

Countries

India

Contacts

Public ContactDr Rajender Singh

Institute for Ayurved Studies and Research Shri Krishna AYUSH University Kurukshetra

drrajendersingh1346@gmail.com9416662761

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026